1.
|
Phase: Phase III Type: Treatment Status: Closed Age: any age Sponsor: Protocol IDs: CAN-NCIC-CO7, CNR-GIVIO-CO3, EORTC-40923, NCI-V94-0464, CO7
|
|
2.
|
Phase: Phase III Type: Treatment Status: Closed Age: 75 and under Sponsor: Protocol IDs: CNR-GISCAD-011909, EU-93022
|
|
3.
|
Phase: Phase III Type: Treatment Status: Closed Age: any age Sponsor: Protocol IDs: NCRI-QUASAR, EU-94045, UKCCCR-QUASAR
|
|
4.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: CNR-INTACC01, EU-95018
|
|
5.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: NCRI-QUASAR1, EU-99053, UKCCCR-QUASAR1, NCT00005586, ISRCTN82375386
|
|
6.
|
Phase: Phase III Type: Treatment Status: Completed Age: 30 and under Sponsor: NCI Protocol IDs: COG-8651, NCI-87-C-68A, NCI-T87-0134N, POG-8651
|
|
7.
|
Phase: Phase III Type: Treatment Status: Closed Age: age not specified Sponsor: Protocol IDs: EORTC-40911
|
|
8.
|
Phase: Phase II Type: Treatment Status: Closed Age: under 75 Sponsor: Protocol IDs: GOCS-09-CR-92, NCI-F95-0028
|
|
9.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: SA-JHB-CUP-1, NCI-F95-0033
|
|
10.
|
Phase: Phase II Type: Treatment Status: Closed Age: over 18 Sponsor: Protocol IDs: DMS-9123, NCI-V92-0054
|
|
11.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: CWRCC-1291, NCI-T92-0015D, T92-0015
|
|
12.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: RPMI-DS-8930, NCI-V89-0272
|